R. Donald Harvey, III, PharmD, BCOP, FCCP, FHOPA
Department of Pharmacology
Department of Hematology and Medical Oncology
Emory University School of Medicine
Director, Phase I Clinical Trials Section
Winship Cancer Institute of Emory University
Dr. R. Donald Harvey received his doctor of pharmacy degree from the University of North Carolina (UNC) at Chapel Hill. He completed a hematology/oncology specialty residency at UNC Hospitals and School of Pharmacy, and a pharmacy practice residency at the University of Kentucky Medical Center and College of Pharmacy. Dr. Harvey is an Associate Professor in the Department of Pharmacology and the Department of Hematology and Medical Oncology at Emory University School of Medicine. In addition, he is Director of the Phase I Clinical Trials Section at the Winship Cancer Institute of Emory University in Atlanta, Georgia.
Dr. Harvey holds memberships in the American Society for Clinical Pharmacology and Therapeutics, International Society of Oncology Pharmacy Practitioners, American Society of Hematology, American Society of Clinical Oncology, Hematology-Oncology Pharmacists Association, and the American College of Clinical Pharmacy. He has published more than 60 peer-reviewed articles and has been a principal or co-investigator on more than 80 early phase trials. Dr. Harvey is on the editorial board of the Journal of Oncology Pharmacy Practice and Pharmacotherapy. In addition, he is a manuscript reviewer for the British Journal of Clinical Pharmacology, Clinical Cancer Research, Investigational New Drugs, British Journal of Cancer, Annals of Oncology, Cancer, and the Journal of Clinical Pharmacology, among others. Dr. Harvey’s research focuses on the application of clinical pharmacology principles to improve cancer treatment outcomes.